Josephine Martin was previously EVP of public affairs at PhRMA.
Meet Medela's Katie Busse, Intouch Solutions' Andrew Grojean, Heartbeat's Meghan Kate, Fingerpaint's Travis Rooke, and Havas Life Metro's Dan Sorine.
Several of the top-spending brands have never hired more than one female or non-white marketing boss, and some never have.
Apologies to Paul Simon, but there must be 50 ways to leave your employer.
Opdivo/Yervoy combination shows improved survival for melanoma patients in trial; global immunotherapy market likely to reach $75 billion by 2022; Mylan expands EpiPen recall
Agency vets Nadine Leonard and James Talerico to co-lead Publicis-owned shop.
Alexion names former Baxalta head as CEO; U.S. dollar drops after AHCA-fail; EMA advises suspension of 300 generic drugs by Indian drugmaker
P&G's Mark Chakravarty has joined pharma giant Novartis in a senior role.
Five highly placed insiders in a range of roles and therapeutic categories share secrets to their success and advice that served them well along the way.
Healthcare is sometimes about life or death, but is almost always about quality of life, says the EVP of health system products and strategy.
Seven execs from A-list agencies weigh in on talent acquisition and retention.
Ten drugmakers seek to exclude pricing information from proxy ballots; roughly 85% of patient advocacy groups get industry funding; Juno halts lead CAR-T project
Dennis Urbaniak has also been named chief digital officer at Havas Lynx.
Novo Nordisk appoints new CEO, and more people moves for you to know about
Novo Nordisk CEO describes 'volatile' pricing environment; Lilly to cut 200 research and development jobs; pharma opts out of Super Bowl this year
A bout with Lyme disease led Yee to found a company that helps patients measure and track their breathing patterns.
Pharma among top sponsors of Trump inauguration parties; AstraZeneca exec to replace GSK president of global pharmaceuticals; EpiPen rival to relaunch
Deborah Furey will lead the agency's pilot of a new personalized marketing offering.
MM&M last year named its inaugural class of 16 Femmes and 20 Women to Watch. Who should be considered for this year's list of breakthough women?
Think back on your career. Did you take the "riskier" assignments?
Endo hires new head of U.S. branded pharma, and three other people moves for you to know about.
DeViteri started in the newly created role this month.
She says her experience in consumer brands helps her push healthcare clients to be more creative.
The merger of Quintiles and IMS Health closed in October.
Sanofi, Regeneron denied bid to overturn Amgen win in patent case; Abbott to close St. Jude deal; Gilead hires SVP of hematology and oncology
Many young staffers agree one of the biggest challenges in their careers has been learning the delicate balance of when to speak up and when to listen.
MM&M conducted Q&As with Stephanie Robinson, senior account manager, The Bloc; Jessica Hill, account supervisor, Ogilvy CommonHealth; and Austin Bald, account executive, TBWA\WorldHealth.
Lilly to offer discounts for insulin products; Trump reportedly considering Scott Gottlieb to lead FDA; three execs depart Valeant
BMS to pay $19.5 million to settle marketing violations for Abilify; AstraZeneca to cut 700 U.S. jobs; Trump reportedly considering Jim O'Neill to lead FDA
Wilson will succeed founder and CEO John Seng.
- Five things for pharma marketers to know: Monday, April 24, 2017
- Five things for pharma marketers to know: Tuesday, April 25, 2017
- Drugmakers battle for slice of Humira's billions
- Five things for pharma marketers to know: Wednesday, April 26, 2017
- Five things for pharma marketers to know: Thursday, April 27, 2017
MM&M honors 40 upstarts and veteran innovation gurus.
For the first time MM&M honors a group of 10 agency execs.